In 2019, the Department of Health started providing the antiretroviral drug dolutegravir as part of HIV treatment in the public sector. Three years later, close to 3.2 million people in South Africa are taking dolutegravir every day. Even so, the rollout of dolutegravir hasn’t all been smooth sailing. Elri Voigt investigates how the massive undertaking of switching millions of people to a new drug has gone.
Though the numbers are relatively uncertain, it is estimated that between four and five million people in South Africa are living with diabetes. One reason for the uncertainty is a lack of testing. A lack of testing also means that many people get diagnosed too late in the course of the disease. Elri Voigt asks what we do and do not know about diabetes in the country and what should be done about it.